- Oral presentation
- Open Access
Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests
© Krivosic-Horber et al; licensee BioMed Central Ltd. 2014
Published: 18 August 2014
Malignant hyperthermia (MH) is a complication of anaesthesia appearing as an acute potentially lethal hypermetabolic state in people carrying a genetic anomaly expressed in the skeletal muscle. MH susceptibility can be diagnosed by in vitro contracture test (IVCT) with halothane and caffeine requiring muscular biopsy, or by looking for the MH mutations directly in DNA extracted from the blood. Studies showed an influence of the type of mutation (genotype) on the various expressions (phenotypes) of the MH susceptibility. The aims of this study are to look for any correlation between the presence of a MH mutation and 1) the severity of the anesthetic complication and 2) the force of the contractures observed in the IVCT.
Materials and methods
Observational analytical retrospective anonymized study based on the informations contained in the Lille MH Database. The criteria of inclusion were: 1) anesthetic probands classified as MHS according to the IVCT and/or the presence of a MH mutation in the RYR1 gene in at least one family member and 2) existence of sufficient clinical information concerning the crisis. The severity of the MH crisis was classified as: death, survival after stay in intensive care unit ICU, survival without stay in ICU. The results of the IVCT: maximal force of contracture at halothane 2%, caffeine 2mmol/L, halothane 3%. The statistical analysis was carried out with a test of Chi-2 for the comparisons of frequency and a test of Mann Whitney for the nonparametric variables with p<0,05 significant.
Severity of malignant hyperthermia reaction and force of contracture of the In-vitro-contracture test
Alive stay ICU
Alive no stay ICU
Force of contracture
Caf 2mmol g
In this study, the severity of the MH crisis is not related to the presence of MH mutations. It is well known that the severity is more dependent on environmental factors, age of the crisis, exposure time to the volatile anesthetic agents, administration of dantrolene. On the other hand, the presence of a MH mutation in gene RYR1 modifies the muscular phenotype since the force of contracture in the IVCT is significantly more important in this group. These results support the genetic heterogeneity of the disease.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.